On "world encephalitis day", The
Asian Society for Pediatric Infectious Diseases (Aspid) and 15 medical societies
issued this statement to bring the awareness to "Encephalitis" which
involves brain inflammation being caused by bacteria, viruses and other
pathogens and “Encephalopathy”, a non-inflammatory brain disorder associated
with various infectious agents because of the dysregulated host immune
response. Encephalitis / Encephalopathy causes high mortality and morbidity
worldwide. Patients that have suffered from encephalitis / encephalopathy can
exhibit persistent symptoms that include behavioral problems, tic disorders,
recurrent headaches, sleeping disorders, motor disabilities and neurocognitive
impairment impacting the lives of many affected people and their families in a
significant way. We sincerely hope to draw the attention and involvement of
different professionals from various disciplines to the coordinated multidisciplinary
care of these individuals and their families.
Early identification of the symptoms and
signs of encephalitis / encephalopathy can help in timely diagnosis and
treatment, alleviating the long-term complications of encephalitis /
encephalopathy.
These symptoms and signs include:
•
Fever
•
Headache
•
Sensitivity
to light and/or sound
•
Neck
stiffness
•
Sleepiness
or lethargy
•
Increased
irritability
•
Seizures
•
Skin
rashes
•
Difficulty
talking and speech changes
•
Changes
in alertness, confusion, or hallucinations
•
Loss
of energy
•
Loss
of appetite
•
Unsteady
gait
•
Nausea
and vomiting
Most importantly, some of the viral causes
of acute encephalitis / encephalopathy are preventable through vaccination,
e.g. Influenza, Covid-19, Dengue Virus, Japanese Encephalitis Virus, Measles, Mumps
and Rubella (MMR) and Varicella Zoster Virus, etc.
We do hope our professionals would promote
the appropriate vaccines to each individual in his/her living circumstance
according to his/her health risks assessment.
Members of the Asian Society For Pediatric
Infectious Diseases (ASPID) remain commiʃed to working in accordance with the
latest scientific evidence, particularly regarding vaccine development,
recommendations, and implementation. ASPID will continue to collaborate closely
with regional and international partners to monitor emerging infectious
diseases, support effective immunisation programs, and promote vaccine
confidence to protect the health of children and communities across Asia and
beyond.